EXOZ to host Q2 2026 investor update on Aug 20 @ 5PM Eastern
press releaseinvestor
EXOZ to host Q2 2026 investor update on Aug 20 @ 5PM EasternAugust 11, 2026
EXOZ and LBNL awarded Genesis Mission grant from DOE
heltzenpress releasescience
eXoZymes selected for DoE’s Genesis Mission to advance AI-powered digital twins for cell-free biomanufacturingJuly 23, 2026
Webull 'Biotech Sector' webinar by Perriman
investorpress clippingsvideopodcastperriman
Webull: 'Biotech Sector' webinar by Damien PerrimanJune 30, 2026
Biomass Magazine
biofuelmedicinepress clippingsscience
Biomass Magazine: Why Use Living Cells? NLR Is Making Chemicals With Enzymes AloneJune 29, 2026
Bionity.com
press clippingscannabinoids
Bionity.com: EXOZ awarded $2M NIH grant to advance cannabinoid analogues for drug discoveryJune 26, 2026
PRISM MarketView
press clippingscannabinoids
PRISM MarketView: NIH Cash Fuels eXoZymes’ Push Into Next‑Gen CannabinoidsJune 25, 2026
Ladder17 podcast: How eXoZymes is Scaling as a Public Company
nutraceuticalspress clippingspodcastperrimanNCT
Ladder17 podcast: How eXoZymes is Scaling as a Public CompanyJune 25, 2026
EXOZ gets $2 Million NIH Grant to Advance Cannabinoids for Drug Discovery
heltzenpress releaseinvestormedicinesciencecannabinoidskorman
eXoZymes Awarded $2 Million NIH Grant to Advance Cannabinoid Analogs for Drug DiscoveryJune 24, 2026
Scientist
jobs
ScientistJune 23, 2026
Process Development Engineer
jobs
Process Development EngineerJune 23, 2026
Previous page
Page 1 of 14
Next page